1 Cholesterol Lowering Biologic Drugs Market Overview 1.1 Product Overview and Scope of Cholesterol Lowering Biologic Drugs 1.2 Cholesterol Lowering Biologic Drugs Segment by Type 1.2.1 Global Cholesterol Lowering Biologic Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Oral 1.2.3 Injectable 1.3 Cholesterol Lowering Biologic Drugs Segment by Application 1.3.1 Global Cholesterol Lowering Biologic Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Drug Stores 1.3.5 Online Sales 1.4 Global Cholesterol Lowering Biologic Drugs Market Size Estimates and Forecasts 1.4.1 Global Cholesterol Lowering Biologic Drugs Revenue 2016-2027 1.4.2 Global Cholesterol Lowering Biologic Drugs Sales 2016-2027 1.4.3 Cholesterol Lowering Biologic Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Cholesterol Lowering Biologic Drugs Market Competition by Manufacturers 2.1 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Cholesterol Lowering Biologic Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Cholesterol Lowering Biologic Drugs Manufacturing Sites, Area Served, Product Type 2.5 Cholesterol Lowering Biologic Drugs Market Competitive Situation and Trends 2.5.1 Cholesterol Lowering Biologic Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Cholesterol Lowering Biologic Drugs Players Market Share by Revenue 2.5.3 Global Cholesterol Lowering Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Cholesterol Lowering Biologic Drugs Retrospective Market Scenario by Region 3.1 Global Cholesterol Lowering Biologic Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Cholesterol Lowering Biologic Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country 3.3.1 North America Cholesterol Lowering Biologic Drugs Sales by Country 3.3.2 North America Cholesterol Lowering Biologic Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country 3.4.1 Europe Cholesterol Lowering Biologic Drugs Sales by Country 3.4.2 Europe Cholesterol Lowering Biologic Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Cholesterol Lowering Biologic Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Region 3.5.2 Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country 3.6.1 Latin America Cholesterol Lowering Biologic Drugs Sales by Country 3.6.2 Latin America Cholesterol Lowering Biologic Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Country 3.7.2 Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Cholesterol Lowering Biologic Drugs Historic Market Analysis by Type 4.1 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2016-2021) 4.2 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Cholesterol Lowering Biologic Drugs Price by Type (2016-2021) 5 Global Cholesterol Lowering Biologic Drugs Historic Market Analysis by Application 5.1 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2016-2021) 5.2 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Cholesterol Lowering Biologic Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Amgen 6.1.1 Amgen Corporation Information 6.1.2 Amgen Description and Business Overview 6.1.3 Amgen Cholesterol Lowering Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Amgen Cholesterol Lowering Biologic Drugs Product Portfolio 6.1.5 Amgen Recent Developments/Updates 6.2 Regeneron Pharmaceuticals 6.2.1 Regeneron Pharmaceuticals Corporation Information 6.2.2 Regeneron Pharmaceuticals Description and Business Overview 6.2.3 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Portfolio 6.2.5 Regeneron Pharmaceuticals Recent Developments/Updates 6.3 Alnylam Pharmaceuticals 6.3.1 Alnylam Pharmaceuticals Corporation Information 6.3.2 Alnylam Pharmaceuticals Description and Business Overview 6.3.3 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Portfolio 6.3.5 Alnylam Pharmaceuticals Recent Developments/Updates 7 Cholesterol Lowering Biologic Drugs Manufacturing Cost Analysis 7.1 Cholesterol Lowering Biologic Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Cholesterol Lowering Biologic Drugs 7.4 Cholesterol Lowering Biologic Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Cholesterol Lowering Biologic Drugs Distributors List 8.3 Cholesterol Lowering Biologic Drugs Customers 9 Cholesterol Lowering Biologic Drugs Market Dynamics 9.1 Cholesterol Lowering Biologic Drugs Industry Trends 9.2 Cholesterol Lowering Biologic Drugs Growth Drivers 9.3 Cholesterol Lowering Biologic Drugs Market Challenges 9.4 Cholesterol Lowering Biologic Drugs Market Restraints 10 Global Market Forecast 10.1 Cholesterol Lowering Biologic Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Cholesterol Lowering Biologic Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Cholesterol Lowering Biologic Drugs by Type (2022-2027) 10.2 Cholesterol Lowering Biologic Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Cholesterol Lowering Biologic Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Cholesterol Lowering Biologic Drugs by Application (2022-2027) 10.3 Cholesterol Lowering Biologic Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Cholesterol Lowering Biologic Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Cholesterol Lowering Biologic Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Cholesterol Lowering Biologic Drugs Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Cholesterol Lowering Biologic Drugs Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Cholesterol Lowering Biologic Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Cholesterol Lowering Biologic Drugs Covered in This Study Table 5. Global Cholesterol Lowering Biologic Drugs Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global Cholesterol Lowering Biologic Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Cholesterol Lowering Biologic Drugs Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Cholesterol Lowering Biologic Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Cholesterol Lowering Biologic Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Cholesterol Lowering Biologic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholesterol Lowering Biologic Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Cholesterol Lowering Biologic Drugs Sales by Region (2016-2021) & (K MT) Table 16. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2016-2021) Table 17. Global Cholesterol Lowering Biologic Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Cholesterol Lowering Biologic Drugs Sales by Country (2016-2021) & (K MT) Table 19. North America Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2016-2021) Table 20. North America Cholesterol Lowering Biologic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Cholesterol Lowering Biologic Drugs Sales by Country (2016-2021) & (K MT) Table 23. Europe Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Cholesterol Lowering Biologic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Cholesterol Lowering Biologic Drugs Sales by Country (2016-2021) & (K MT) Table 31. Latin America Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Cholesterol Lowering Biologic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Cholesterol Lowering Biologic Drugs Sales (K MT) by Type (2016-2021) Table 39. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2016-2021) Table 40. Global Cholesterol Lowering Biologic Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Cholesterol Lowering Biologic Drugs Revenue Share by Type (2016-2021) Table 42. Global Cholesterol Lowering Biologic Drugs Price (USD/MT) by Type (2016-2021) Table 43. Global Cholesterol Lowering Biologic Drugs Sales (K MT) by Application (2016-2021) Table 44. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2016-2021) Table 45. Global Cholesterol Lowering Biologic Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Cholesterol Lowering Biologic Drugs Revenue Share by Application (2016-2021) Table 47. Global Cholesterol Lowering Biologic Drugs Price (USD/MT) by Application (2016-2021) Table 48. Amgen Corporation Information Table 49. Amgen Description and Business Overview Table 50. Amgen Cholesterol Lowering Biologic Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Amgen Cholesterol Lowering Biologic Drugs Product Table 52. Amgen Recent Developments/Updates Table 53. Regeneron Pharmaceuticals Corporation Information Table 54. Regeneron Pharmaceuticals Description and Business Overview Table 55. Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Table 57. Regeneron Pharmaceuticals Recent Developments/Updates Table 58. Alnylam Pharmaceuticals Corporation Information Table 59. Alnylam Pharmaceuticals Description and Business Overview Table 60. Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Table 62. Alnylam Pharmaceuticals Recent Developments/Updates Table 63. Production Base and Market Concentration Rate of Raw Material Table 64. Key Suppliers of Raw Materials Table 65. Cholesterol Lowering Biologic Drugs Distributors List Table 66. Cholesterol Lowering Biologic Drugs Customers List Table 67. Cholesterol Lowering Biologic Drugs Market Trends Table 68. Cholesterol Lowering Biologic Drugs Growth Drivers Table 69. Cholesterol Lowering Biologic Drugs Market Challenges Table 70. Cholesterol Lowering Biologic Drugs Market Restraints Table 71. Global Cholesterol Lowering Biologic Drugs Sales Forecast by Type (2022-2027) & (K MT) Table 72. Global Cholesterol Lowering Biologic Drugs Sales Market Share Forecast by Type (2022-2027) Table 73. Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 74. Global Cholesterol Lowering Biologic Drugs Revenue Market Share Forecast by Type (2022-2027) Table 75. Global Cholesterol Lowering Biologic Drugs Sales Forecast by Application (2022-2027) & (K MT) Table 76. Global Cholesterol Lowering Biologic Drugs Sales Market Share Forecast by Application (2022-2027) Table 77. Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 78. Global Cholesterol Lowering Biologic Drugs Revenue Market Share Forecast by Application (2022-2027) Table 79. Global Cholesterol Lowering Biologic Drugs Sales Forecast by Region (2022-2027) & (K MT) Table 80. Global Cholesterol Lowering Biologic Drugs Sales Market Share Forecast by Region (2022-2027) Table 81. Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 82. Global Cholesterol Lowering Biologic Drugs Revenue Market Share Forecast by Region (2022-2027) Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Cholesterol Lowering Biologic Drugs Figure 2. Global Cholesterol Lowering Biologic Drugs Market Share by Type in 2020 & 2027 Figure 3. Oral Product Picture Figure 4. Injectable Product Picture Figure 5. Global Cholesterol Lowering Biologic Drugs Market Share by Application in 2020 & 2027 Figure 6. Hospital Pharmacies Figure 7. Retail Pharmacies Figure 8. Drug Stores Figure 9. Online Sales Figure 10. Global Cholesterol Lowering Biologic Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Cholesterol Lowering Biologic Drugs Market Size 2016-2027 (US$ Million) Figure 12. Global Cholesterol Lowering Biologic Drugs Sales 2016-2027 (K MT) Figure 13. Global Cholesterol Lowering Biologic Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Cholesterol Lowering Biologic Drugs Sales Share by Manufacturers in 2020 Figure 15. Global Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Cholesterol Lowering Biologic Drugs Players: Market Share by Revenue in 2020 Figure 17. Cholesterol Lowering Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2016-2021) Figure 19. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Region in 2020 Figure 20. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Region (2016-2021) Figure 21. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Region in 2020 Figure 22. U.S. Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Cholesterol Lowering Biologic Drugs by Type (2016-2021) Figure 47. Sales Market Share of Cholesterol Lowering Biologic Drugs by Application (2016-2021) Figure 48. Sales Market Share of Cholesterol Lowering Biologic Drugs by Application in 2020 Figure 49. Revenue Share of Cholesterol Lowering Biologic Drugs by Application (2016-2021) Figure 50. Revenue Share of Cholesterol Lowering Biologic Drugs by Application in 2020 Figure 51. Manufacturing Cost Structure of Cholesterol Lowering Biologic Drugs Figure 52. Manufacturing Process Analysis of Cholesterol Lowering Biologic Drugs Figure 53. Cholesterol Lowering Biologic Drugs Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Amgen Regeneron Pharmaceuticals Alnylam Pharmaceuticals